ExoticRx · exoticrx.com/drugs/fuzapladib
US brand names:Panoquell-CA1
Fuzapladib is dosed at 0.1 mg/kg IV Single dose in dogs, per FDA conditional approval (Laverdia-CA1); FDA openFDA Adverse Event Database. Verify against current literature before clinical use.
Inhibits cytosolic phospholipase A2 (cPLA2), reducing arachidonic acid release from cell membranes and subsequent production of both prostaglandins and leukotrienes, providing broad anti-inflammatory effects.
New veterinary drug — limited long-term safety data. Monitor for GI signs and injection site reactions. Currently indicated for canine use only.
Species references:All Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 1 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 0.1 mg/kg | Single dose | Moderate | FDA conditional approval (Laverdia-CA1); FDA openFDA Adverse Event Database |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.